Remotely Delivered Mindfulness-Based Diabetes Education - Trial NCT06312553
Access comprehensive clinical trial information for NCT06312553 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Alabama at Birmingham and is currently Not yet recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Remotely delivered Mindfulness-Based Diabetes Education with remote patient monitoring
Interventional
behavioral
Sponsor & Location
University of Alabama at Birmingham
Timeline & Enrollment
N/A
Jul 01, 2024
Jun 30, 2026
Primary Outcome
Feasibility: percentage of screened participants who are eligible,Feasibility: percentage of eligible participants who enroll,Feasibility: ability to randomize participants to study arms,Feasibility: distribution of participants by demographics,Feasibility: percentage of sessions attended,Feasibility: participant adherence to study tasks include home mindfulness practices, self-monitoring activities.,Feasibility: barriers to participation in intervention sessions or completing study activities at home,Feasibility: reasons for dropping out,Feasibility: overall study retention,Acceptability
Summary
Diabetes distress is common affecting over one-third of people with type 2 diabetes,
 negatively impacting self-management and outcomes, and disproportionately affecting
 low-income individuals. The proposed project will conduct a pilot randomized controlled trial
 comparing remotely delivered Mindfulness-Based Diabetes Education plus remote patient
 monitoring of blood glucose to standard Diabetes Self-Management Education in rural Black
 adults with type 2 diabetes and elevated diabetes distress who receive care within federally
 qualified health centers to assess feasibility and acceptability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06312553
Non-Device Trial